Interestingly, Pyk2 could still co-immunoprecipitate with p130Cas in FAK-ablated tumour lysates (Figure S5d in Additional file 5), suggesting that the remaining levels of p130Cas phosphorylation were due to the ability of Pyk2 to functionally substitute for FAK. The gene discussed is PTK2B; the disease is neoplasm.